Literature DB >> 16200615

An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles.

James Chesko1, Jina Kazzaz, Mildred Ugozzoli, Derek T O'hagan, Manmohan Singh.   

Abstract

This work examines physico-chemical properties influencing protein adsorption to anionic PLG microparticles and demonstrates the ability to bind and release vaccine antigens over a range of loads, pH values, and ionic strengths. Poly(lactide-co-glycolide) microparticles were synthesized by a w/o/w emulsification method in the presence of the anionic surfactant DSS (dioctyl sodium sulfosuccinate). Ovalbumin (OVA), carbonic anhydrase (CAN), lysozyme (LYZ), lactic acid dehydrogenase, bovine serum albumin (BSA), an HIV envelope glyocoprotein, and a Neisseria meningitidis B protein were adsorbed to the PLG microparticles, with binding efficiency, initial release and zeta potentials measured. Protein (antigen) binding to PLG microparticles was influenced by both electrostatic interaction and other mechanisms such as van der Waals forces. The protein binding capacity was directly proportional to the available surface area and may have a practical upper limit imposed by the formation of a complete protein monolayer as suggested by AFM images. The protein affinity for the PLG surface depended strongly on the isoelectric point (pI) and electrostatic forces, but also showed contributions from nonCoulombic interactions. Protein antigens were adsorbed on anionic PLG microparticles with varying degrees of efficiency under different conditions such as pH and ionic strength. Observable changes in zeta potentials and morphology suggest the formation of a surface monolayer. Antigen binding and release occur through a combination of electrostatic and van der Waals interactions occurring at the polymer-solution interface.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200615     DOI: 10.1002/jps.20472

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

Review 1.  Peptide/protein vaccine delivery system based on PLGA particles.

Authors:  Mojgan Allahyari; Elham Mohit
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis.

Authors:  Weifeng Zhang; Lianyan Wang; Yuan Liu; Xiaoming Chen; Jiahui Li; Tingyuan Yang; Wenqi An; Xiaowei Ma; Ruowen Pan; Guanghui Ma
Journal:  Pharm Res       Date:  2013-10-30       Impact factor: 4.200

Review 3.  Mucosal vaccines: recent progress in understanding the natural barriers.

Authors:  Olga Borges; Filipa Lebre; Dulce Bento; Gerrit Borchard; Hans E Junginger
Journal:  Pharm Res       Date:  2009-12-01       Impact factor: 4.200

4.  Working together: interactions between vaccine antigens and adjuvants.

Authors:  Christopher B Fox; Ryan M Kramer; Lucien Barnes V; Quinton M Dowling; Thomas S Vedvick
Journal:  Ther Adv Vaccines       Date:  2013-05

5.  Growth of hydroxyapatite coatings on biodegradable polymer microspheres.

Authors:  Leenaporn Jongpaiboonkit; Travelle Franklin-Ford; William L Murphy
Journal:  ACS Appl Mater Interfaces       Date:  2009-07       Impact factor: 9.229

6.  Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.

Authors:  Mauricio A Arias; Andrew Loxley; Christy Eatmon; Griet Van Roey; David Fairhurst; Mark Mitchnick; Philip Dash; Tom Cole; Frank Wegmann; Quentin Sattentau; Robin Shattock
Journal:  Vaccine       Date:  2010-12-09       Impact factor: 3.641

7.  Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines.

Authors:  Fausto Titti; Maria T Maggiorella; Flavia Ferrantelli; Leonardo Sernicola; Stefania Bellino; Barbara Collacchi; Emanuele Fanales Belasio; Sonia Moretti; Maria Rosaria Pavone Cossut; Roberto Belli; Erika Olivieri; Stefania Farcomeni; Daniela Compagnoni; Zuleika Michelini; Michela Sabbatucci; Katia Sparnacci; Luisa Tondelli; Michele Laus; Aurelio Cafaro; Antonella Caputo; Barbara Ensoli
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

8.  Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases.

Authors:  Christopher J Genito; Cole J Batty; Eric M Bachelder; Kristy M Ainslie
Journal:  Adv Nanobiomed Res       Date:  2021-01-18

Review 9.  The Use of Synthetic Carriers in Malaria Vaccine Design.

Authors:  Liam Powles; Sue D Xiang; Cordelia Selomulya; Magdalena Plebanski
Journal:  Vaccines (Basel)       Date:  2015-10-29

10.  Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles.

Authors:  Malgosia M Pakulska; Irja Elliott Donaghue; Jaclyn M Obermeyer; Anup Tuladhar; Christopher K McLaughlin; Tyler N Shendruk; Molly S Shoichet
Journal:  Sci Adv       Date:  2016-05-27       Impact factor: 14.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.